Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in southeastern Michigan

Infection Control and Hospital Epidemiology

Volumn 34, Issue 9, 2013, Pages 954-960

  Tosh, Pritish K ^a,b,c   Agolory, Simon ^a   Strong, Bethany L ^b,d,j   VerLee, Kerrie ^e,f   Finks, Jennie ^e   Hayakawa, Kayoko ^g   Chopra, Teena ^g   Kaye, Keith S ^g   Gilpin, Nicholas ^h   Carpenter, Christopher F ^h   Haque, Nadia Z ⁱ   Lamarato, Lois E ⁱ   Zervos, Marcus J ⁱ   Albrecht, Valerie S ^b   McAllister, Sigrid K ^b   Limbago, Brandi ^b   MacCannell, Duncan R ^b   McDougal, Linda K ^b   Kallen, Alexander J ^b   Guh, Alice Y ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c MAYO CLINIC   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^f Council of State and Territorial Epidemiologists   (United States)

^g DETROIT MEDICAL CENTER   (United States)

^h William Beaumont Hospitals   (United States)

ⁱ HENRY FORD HEALTH SYSTEM   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CASE CONTROL STUDY; FEMALE; HUMAN; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; UNITED STATES; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; WOUND;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LEG INJURIES; MALE; MICHIGAN; MIDDLE AGED; PREVALENCE; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN RESISTANCE; WOUND INFECTION;

EID: 84881136735     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/671735     Document Type: Article

References (20)

1. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin-United States, 2002.MMWR Morb Mortal Wkly Rep 2002;51:565-567.
2. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis 2008;46:668-674.
3. Centers for Disease Control and Prevention. CDC reminds clin-ical laboratories and healthcare infection preventionists of their role in the search and containment of vancomycin-resistant Staphylococcus aureus (VRSA). http://www.cdc.gov/HAI/settings/lab/vrsa_search_containment.html. Accessed June 21, 2012.
4. de Niederhausern S, Bondi M, Messi P, et al. Vancomycinresistance transferability from VanA enterococci to Staphylococcus aureus. Curr Microbiol 2011;62:1363-1367.
5. Zhu W, Murray PR, Huskins WC, et al. Dissemination of an enterococcus Inc18-like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2010;54:4314-4320.
6. McDougal LK, Fosheim GE, Nicholson A, et al. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob Agents Chemother 2010;54:3804-3811.
7. Zhu W, Clark NC, McDougal LK, Hageman J, McDonald LC, Patel JB. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan. Antimicrob Agents Chemother 2008;52:452-457.
8. Zhu W, Clark NC, Patel JB. pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro. Antimicrob Agents Chemother 2012;57:212-219.
9. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus-Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep 2002;51:902.
10. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus-New York, 2004. MMWR Morb Mortal Wkly Rep 2004;53:322-323.
11. Finks J, Wells E, Dyke TL, et al. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007. Emerg Infect Dis 2009;15: 943-945.
12. Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycinresistant Staphylococcus aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother 2004;48:275-280.
13. Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41:5442-5448.
14. Limbago B, Fosheim GE, Schoonover V, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. J Clin Microbiol 2009;47:1344-1351.
15. Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist 1970;10:20-30.
16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
17. Flannery EL, Wang L, Zollner S, Foxman B, Mobley HL, Mody L. Wounds, functional disability, and indwelling devices are associated with cocolonization by methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in southeast Michigan. Clin Infect Dis 2011;53:1215-1222.
18. Mermel LA, Eells SJ, Acharya MK, et al. Quantitative analysis and molecular fingerprinting of methicillin-resistant Staphylococcus aureus nasal colonization in different patient populations: a prospective, multicenter study. Infect Control Hosp Epidemiol 2010;31:592-597.
19. Scanvic A, Denic L, Gaillon S, Giry P, Andremont A, Lucet JC. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001;32:1393-1398.
20. Weigel LM, Donlan RM, Shin DH, et al. High-level vancomycinresistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 2007;51:231-238.